CAMBRIDGE, Mass. and SUZHOU, China, May 8, 2023 /PRNewswire/ — Neuro3 Therapeutics (Neuro3), a biotechnology company focused on the discovery and development of innovative medicines for the treatment of central nervous system (CNS) diseases, announced today the signing of an exclusive,…